Temat: "Recurrence" - OpacWWW

Skocz do pozycji: 1 1.

Tytuł :: The EPIC procedure (Endoscopic-assisted Pilonidal Irrigation and Cleaning): a simple and effective treatment for pilonidal disease.
Autorzy :: Baxter J; Western Michigan University Homer Stryker MD School of Medicine, Kalamazoo, MI, USA.
Espinosa JA; Department of General Surgery, Western Michigan University Homer Stryker MD School of Medicine, Kalamazoo, MI, USA.
Leinwand MJ; Department of General Surgery, Western Michigan University Homer Stryker MD School of Medicine, Kalamazoo, MI, USA. .; Department of Pediatric Surgery, Bronson Children's Hospital, 601 John St., Suite M-351, Kalamazoo, MI, USA. .; Pokaż więcej
Źródło :: Surgical endoscopy [Surg Endosc] 2022 Feb; Vol. 36 (2), pp. 1380-1384. Date of Electronic Publication: 2021 Mar 15.
Typ publikacji :: Journal Article
MeSH Terms :: Neoplasm Recurrence, Local*
Pilonidal Sinus*/surgery
Adult ; Child ; Endoscopy/methods ; Humans ; Recurrence ; Retrospective Studies ; Treatment Outcome
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 2 2.

Tytuł :: Prognostic factors of flap techniques for pilonidal disease based on magnetic resonance imaging and clinical parameters.
Autorzy :: Zou Q; Department of Gastrointestinal Surgery, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou 510655, China; Guangdong Provincial Key Laboratory of Colorectal and Pelvic Floor Diseases, Guangdong Institute of Gastroenterology, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou 510655, China.
Zhang D; Department of Gastrointestinal Surgery, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou 510655, China; Guangdong Provincial Key Laboratory of Colorectal and Pelvic Floor Diseases, Guangdong Institute of Gastroenterology, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou 510655, China.
Xian Z; Department of Gastrointestinal Surgery, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou 510655, China; Guangdong Provincial Key Laboratory of Colorectal and Pelvic Floor Diseases, Guangdong Institute of Gastroenterology, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou 510655, China.
Wang X; Department of Gastrointestinal Surgery, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou 510655, China; Guangdong Provincial Key Laboratory of Colorectal and Pelvic Floor Diseases, Guangdong Institute of Gastroenterology, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou 510655, China.
Xie S; Department of Gastrointestinal Surgery, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou 510655, China; Guangdong Provincial Key Laboratory of Colorectal and Pelvic Floor Diseases, Guangdong Institute of Gastroenterology, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou 510655, China.
Hu B; Department of Gastrointestinal Surgery, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou 510655, China; Guangdong Provincial Key Laboratory of Colorectal and Pelvic Floor Diseases, Guangdong Institute of Gastroenterology, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou 510655, China. Electronic address: .
Ren D; Department of Gastrointestinal Surgery, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou 510655, China; Guangdong Provincial Key Laboratory of Colorectal and Pelvic Floor Diseases, Guangdong Institute of Gastroenterology, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou 510655, China. Electronic address: .; Pokaż więcej
Źródło :: Asian journal of surgery [Asian J Surg] 2022 Jan; Vol. 45 (1), pp. 284-290. Date of Electronic Publication: 2021 Jun 20.
Typ publikacji :: Journal Article
MeSH Terms :: Neoplasm Recurrence, Local*
Pilonidal Sinus*/diagnostic imaging
Pilonidal Sinus*/surgery
Humans ; Magnetic Resonance Imaging ; Prognosis ; Recurrence ; Retrospective Studies ; Treatment Outcome
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 3 3.

Tytuł :: A varying-coefficient model for gap times between recurrent events.
Autorzy :: Soh JE; Department of Biostatistics and Bioinformatics, Rollins School of Public Health, Emory University, Atlanta, GA, 30322, USA. .
Huang Y; Department of Biostatistics and Bioinformatics, Rollins School of Public Health, Emory University, Atlanta, GA, 30322, USA.; Pokaż więcej
Źródło :: Lifetime data analysis [Lifetime Data Anal] 2021 Jul; Vol. 27 (3), pp. 437-459. Date of Electronic Publication: 2021 May 08.
Typ publikacji :: Journal Article
MeSH Terms :: Models, Statistical*
Neoplasm Recurrence, Local*
Computer Simulation ; Follow-Up Studies ; Humans ; Monte Carlo Method ; Recurrence ; Sample Size
: Czasopismo naukowe

Szczegóły Pełny tekst Pełny tekst

Skocz do pozycji: 4 4.

Tytuł :: Isolated optic nerve involvement in acute lymphoblastic leukaemia: a red flag for early relapse.
Autorzy :: Azad SV; Dr R P Center for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi, Delhi, India.
Banerjee M; Dr R P Center for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi, Delhi, India .
Parmanand K; Dr R P Center for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi, Delhi, India.
Venkatesh P; Dr R P Center for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi, Delhi, India.; Pokaż więcej
Źródło :: BMJ case reports [BMJ Case Rep] 2021 Jun 28; Vol. 14 (6). Date of Electronic Publication: 2021 Jun 28.
Typ publikacji :: Case Reports; Journal Article
MeSH Terms :: Neoplasm Recurrence, Local*
Precursor Cell Lymphoblastic Leukemia-Lymphoma*/complications
Precursor Cell Lymphoblastic Leukemia-Lymphoma*/drug therapy
Acute Disease ; Central Nervous System ; Child ; Humans ; Optic Nerve/diagnostic imaging ; Recurrence
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 5 5.

Tytuł :: Revisiting miRNA Association with Melanoma Recurrence and Metastasis from a Machine Learning Point of View.
Autorzy :: Korfiati A; Department of Medical Physics, School of Medicine, University of Patras, 26504 Patras, Greece.
Grafanaki K; Department of Dermatology, School of Medicine, University of Patras, 26504 Patras, Greece.
Kyriakopoulos GC; Department of Biochemistry, School of Medicine, University of Patras, 26504 Patras, Greece.
Skeparnias I; Laboratory of Molecular Biology, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD 20892, USA.
Georgiou S; Department of Dermatology, School of Medicine, University of Patras, 26504 Patras, Greece.
Sakellaropoulos G; Department of Medical Physics, School of Medicine, University of Patras, 26504 Patras, Greece.
Stathopoulos C; Department of Biochemistry, School of Medicine, University of Patras, 26504 Patras, Greece.; Pokaż więcej
Źródło :: International journal of molecular sciences [Int J Mol Sci] 2022 Jan 24; Vol. 23 (3). Date of Electronic Publication: 2022 Jan 24.
Typ publikacji :: Journal Article; Review
MeSH Terms :: Melanoma/*genetics
MicroRNAs/*genetics
Neoplasm Recurrence, Local/*genetics
Computational Biology/methods ; Databases, Genetic ; Gene Expression/genetics ; Gene Expression Profiling/methods ; Humans ; Machine Learning ; Melanoma/pathology ; Neoplasm Metastasis/genetics ; Neoplasm Staging ; Prognosis ; Recurrence ; Skin Neoplasms/genetics ; Skin Neoplasms/pathology ; Transcriptome/genetics
SCR Disease Name :: Melanoma, Cutaneous Malignant
: Czasopismo naukowe

Szczegóły Pełny tekst Pełny tekst

Skocz do pozycji: 6 6.

Tytuł :: Monitoring of post-transplant MLL-PTD as minimal residual disease can predict relapse after allogeneic HSCT in patients with acute myeloid leukemia and myelodysplastic syndrome.
Autorzy :: Kong J; Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, No 11 Xizhimen South Street, Beijing, 100044, China.
Gao MG; Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, No 11 Xizhimen South Street, Beijing, 100044, China.
Qin YZ; Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, No 11 Xizhimen South Street, Beijing, 100044, China.
Wang Y; Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, No 11 Xizhimen South Street, Beijing, 100044, China.
Yan CH; Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, No 11 Xizhimen South Street, Beijing, 100044, China.; Research Unit of Key Technique for Diagnosis and Treatments of Hematologic Malignancies, Chinese Academy of Medical Sciences, 2019RU029, Beijing, China.
Sun YQ; Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, No 11 Xizhimen South Street, Beijing, 100044, China.
Chang YJ; Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, No 11 Xizhimen South Street, Beijing, 100044, China.; Research Unit of Key Technique for Diagnosis and Treatments of Hematologic Malignancies, Chinese Academy of Medical Sciences, 2019RU029, Beijing, China.; Collaborative Innovation Center of Hematology, Peking University, Beijing, China.
Xu LP; Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, No 11 Xizhimen South Street, Beijing, 100044, China.; Research Unit of Key Technique for Diagnosis and Treatments of Hematologic Malignancies, Chinese Academy of Medical Sciences, 2019RU029, Beijing, China.
Zhang XH; Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, No 11 Xizhimen South Street, Beijing, 100044, China.
Liu KY; Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, No 11 Xizhimen South Street, Beijing, 100044, China.
Huang XJ; Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, No 11 Xizhimen South Street, Beijing, 100044, China.; Research Unit of Key Technique for Diagnosis and Treatments of Hematologic Malignancies, Chinese Academy of Medical Sciences, 2019RU029, Beijing, China.; Collaborative Innovation Center of Hematology, Peking University, Beijing, China.; Peking-Tsinghua Center for Life Sciences, Beijing, 100044, China.
Zhao XS; Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, No 11 Xizhimen South Street, Beijing, 100044, China. .; Research Unit of Key Technique for Diagnosis and Treatments of Hematologic Malignancies, Chinese Academy of Medical Sciences, 2019RU029, Beijing, China. .; Collaborative Innovation Center of Hematology, Peking University, Beijing, China. .; Pokaż więcej
Źródło :: BMC cancer [BMC Cancer] 2022 Jan 03; Vol. 22 (1), pp. 11. Date of Electronic Publication: 2022 Jan 03.
Typ publikacji :: Journal Article
MeSH Terms :: Histone-Lysine N-Methyltransferase/*genetics
Leukemia, Myeloid, Acute/*genetics
Myelodysplastic Syndromes/*genetics
Myeloid-Lymphoid Leukemia Protein/*genetics
Neoplasm Recurrence, Local/*genetics
Oncogene Proteins, Fusion/*genetics
Disease-Free Survival ; Female ; Follow-Up Studies ; Gene Rearrangement/genetics ; Hematopoietic Stem Cell Transplantation ; Humans ; Leukemia, Myeloid, Acute/mortality ; Leukemia, Myeloid, Acute/surgery ; Male ; Middle Aged ; Myelodysplastic Syndromes/mortality ; Myelodysplastic Syndromes/surgery ; Neoplasm Recurrence, Local/mortality ; Neoplasm, Residual ; Postoperative Period ; Predictive Value of Tests ; Prognosis ; Progression-Free Survival ; Recurrence ; Retrospective Studies ; Transplantation, Homologous ; Tumor Burden/genetics
: Czasopismo naukowe

Szczegóły Pełny tekst Pełny tekst

Skocz do pozycji: 7 7.

Tytuł :: The Current and Future Role of Radiation Therapy in the Era of CAR T-cell Salvage.
Autorzy :: DeSelm C; Washington University School of Medicine in St Louis, St Louis, Missouri.; Pokaż więcej
Źródło :: The British journal of radiology [Br J Radiol] 2021 Nov 01; Vol. 94 (1127), pp. 20210098. Date of Electronic Publication: 2021 Aug 10.
Typ publikacji :: Journal Article; Review
MeSH Terms :: Drug Resistance, Neoplasm*
Lymphoma, Non-Hodgkin/*radiotherapy
Neoplasm Recurrence, Local/*radiotherapy
Receptors, Chimeric Antigen/*therapeutic use
Salvage Therapy/*methods
Lymphoma, Non-Hodgkin/immunology ; Neoplasm Recurrence, Local/immunology ; Receptors, Chimeric Antigen/immunology ; Recurrence ; Salvage Therapy/trends
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 8 8.

Tytuł :: Aberrant Methylation of 20 miRNA Genes Specifically Involved in Various Steps of Ovarian Carcinoma Spread: From Primary Tumors to Peritoneal Macroscopic Metastases.
Autorzy :: Loginov VI; Institute of General Pathology and Pathophysiology, 125315 Moscow, Russia.
Pronina IV; Institute of General Pathology and Pathophysiology, 125315 Moscow, Russia.
Filippova EA; Institute of General Pathology and Pathophysiology, 125315 Moscow, Russia.
Burdennyy AM; Institute of General Pathology and Pathophysiology, 125315 Moscow, Russia.
Lukina SS; Institute of General Pathology and Pathophysiology, 125315 Moscow, Russia.
Kazubskaya TP; N.N. Blokhin National Medical Research Center of Oncology, 115478 Moscow, Russia.
Uroshlev LA; Institute of General Pathology and Pathophysiology, 125315 Moscow, Russia.; Vavilov Institute of General Genetics, Russian Academy of Sciences, 119991 Moscow, Russia.
Fridman MV; Vavilov Institute of General Genetics, Russian Academy of Sciences, 119991 Moscow, Russia.
Brovkina OI; Institute of General Pathology and Pathophysiology, 125315 Moscow, Russia.
Apanovich NV; Research Center for Medical Genetics, 115478 Moscow, Russia.
Karpukhin AV; Research Center for Medical Genetics, 115478 Moscow, Russia.
Stilidi IS; N.N. Blokhin National Medical Research Center of Oncology, 115478 Moscow, Russia.
Kushlinskii NE; N.N. Blokhin National Medical Research Center of Oncology, 115478 Moscow, Russia.
Dmitriev AA; Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, 119991 Moscow, Russia.
Braga EA; Institute of General Pathology and Pathophysiology, 125315 Moscow, Russia.; Pokaż więcej
Źródło :: International journal of molecular sciences [Int J Mol Sci] 2022 Jan 24; Vol. 23 (3). Date of Electronic Publication: 2022 Jan 24.
Typ publikacji :: Journal Article
MeSH Terms :: MicroRNAs/*genetics
Neoplasm Recurrence, Local/*genetics
Ovarian Neoplasms/*genetics
Carcinoma/genetics ; Carcinoma/pathology ; Carcinoma, Ovarian Epithelial/genetics ; Female ; Gene Expression/genetics ; Gene Expression Regulation, Neoplastic/genetics ; Humans ; Machine Learning ; Methylation ; Neoplasm Metastasis/genetics ; Neoplasm Staging ; Ovarian Neoplasms/pathology ; Peritoneum/metabolism ; Prognosis ; Recurrence ; Transcriptome/genetics
: Czasopismo naukowe

Szczegóły Pełny tekst Pełny tekst

Skocz do pozycji: 9 9.

Tytuł :: Pre-analytical processing protocol of breast biopsies affects multigene panel results.
Autorzy :: Lima VR; Clinical Analysis Laboratory of the Medical School of the ABC (FMABC) University Center, Santo André, Brazil.
da Costa Aguiar Alves B; Clinical Analysis Laboratory of the Medical School of the ABC (FMABC) University Center, Santo André, Brazil.
Fonseca FLA; Clinical Analysis Laboratory of the Medical School of the ABC (FMABC) University Center, Santo André, Brazil.; Institute of Pharmaceutical Sciences, Federal University of São Paulo (UNIFESP), Diadema, Brazil.
Zveibil DK; Department of Pathology, Medical School of the ABC (FMABC) University Center, Santo André, Brazil.
Del Giglio A; Discipline of Oncology and Hematology, Medical School of the ABC (FMABC) University Center, Santo André, Brazil.; Pokaż więcej
Źródło :: International journal of experimental pathology [Int J Exp Pathol] 2022 Jun; Vol. 103 (3), pp. 112-120.
Typ publikacji :: Journal Article
MeSH Terms :: Breast Neoplasms*/pathology
Neoplasm Recurrence, Local*/drug therapy
Neoplasm Recurrence, Local*/genetics
Neoplasm Recurrence, Local*/pathology
Biopsy ; Chemotherapy, Adjuvant ; Female ; Gene Expression Profiling/methods ; Humans ; Prognosis
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 10 10.

Tytuł :: Evaluation of Clinical and Pathological Factors to Predict High Risk of Recurrence in Patients With Stage II Colon Cancer.
Autorzy :: Cadham B
Parker B
Yin Y
Gill S
Loree JM
Cheung WY
Davies JM; Pokaż więcej
Źródło :: Clinical colorectal cancer [Clin Colorectal Cancer] 2022 Jun; Vol. 21 (2), pp. e39-e48. Date of Electronic Publication: 2021 Oct 02.
Typ publikacji :: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :: Colonic Neoplasms*/pathology
Neoplasm Recurrence, Local*/epidemiology
Neoplasm Recurrence, Local*/pathology
Humans ; Neoplasm Staging ; Prognosis ; Risk Factors
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 11 11.

Tytuł :: Real world results of venetoclax combined with hypomethylating agents in relapsed/refractory AML.
Autorzy :: Ucar MA; Department of Internal Medicine, Division of Hematology, Faculty of Medicine, Çukurova University, Turkey. .
Ozet G
Koyuncu MB
Sonmez M
Akidan O
Ayli M
Yildirim M
Pehlivan M
Akkurd DM
Sahin H
Guvenc B
Okan V
Tiftik EN
Akdeniz A
Dincyurek HD
Gunes AK
Dagdas S
Acar HI
Ucar HK
Tombak A; Pokaż więcej
Źródło :: European review for medical and pharmacological sciences [Eur Rev Med Pharmacol Sci] 2021 Nov; Vol. 25 (21), pp. 6557-6565.
Typ publikacji :: Journal Article; Multicenter Study
MeSH Terms :: Antineoplastic Agents/*therapeutic use
Bridged Bicyclo Compounds, Heterocyclic/*therapeutic use
Leukemia, Myeloid, Acute/*therapy
Neoplasm Recurrence, Local/*drug therapy
Sulfonamides/*therapeutic use
Adult ; Aged ; Aged, 80 and over ; DNA Methylation ; Female ; Humans ; Male ; Middle Aged ; Recurrence ; Retrospective Studies ; Salvage Therapy ; Stem Cell Transplantation ; Young Adult
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 12 12.

Tytuł :: Salvage radiotherapy for primary refractory and relapsed diffuse large B-Cell lymphoma.
Autorzy :: Brooks ED; Department of Radiation Oncology, University of Florida Health Proton Therapy Institute, Jacksonville, FL, United States.
Fang P; Department of Radiation Oncology, University of Texas M.D. Anderson Cancer Center, Houston, TX, United States.
Pinnix CC; Department of Radiation Oncology, University of Texas M.D. Anderson Cancer Center, Houston, TX, United States.; Pokaż więcej
Źródło :: The British journal of radiology [Br J Radiol] 2021 Nov 01; Vol. 94 (1127), pp. 20210360. Date of Electronic Publication: 2021 Aug 31.
Typ publikacji :: Journal Article; Review
MeSH Terms :: Drug Resistance, Neoplasm*
Lymphoma, Large B-Cell, Diffuse/*radiotherapy
Neoplasm Recurrence, Local/*radiotherapy
Salvage Therapy/*methods
Humans ; Recurrence
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 13 13.

Tytuł :: A meta-analysis of marsupialisation versus none in the treatment of simple fistula-in-ano.
Autorzy :: Sahebally SM; Department of Colorectal Surgery, Beaumont Hospital, Dublin 9, Ireland. .; Royal College of Surgeons, St Stephen's Green, Dublin 2, Ireland. .
O'Byrne L; Department of Colorectal Surgery, Beaumont Hospital, Dublin 9, Ireland.; Royal College of Surgeons, St Stephen's Green, Dublin 2, Ireland.
Troy A; Department of Colorectal Surgery, Beaumont Hospital, Dublin 9, Ireland.; Royal College of Surgeons, St Stephen's Green, Dublin 2, Ireland.
Byrnes KG; Department of Colorectal Surgery, Beaumont Hospital, Dublin 9, Ireland.; Royal College of Surgeons, St Stephen's Green, Dublin 2, Ireland.
Burke J; Department of Colorectal Surgery, Beaumont Hospital, Dublin 9, Ireland.; Royal College of Surgeons, St Stephen's Green, Dublin 2, Ireland.
McNamara D; Department of Colorectal Surgery, Beaumont Hospital, Dublin 9, Ireland.; Royal College of Surgeons, St Stephen's Green, Dublin 2, Ireland.; Pokaż więcej
Źródło :: International journal of colorectal disease [Int J Colorectal Dis] 2021 Mar; Vol. 36 (3), pp. 429-436. Date of Electronic Publication: 2020 Oct 06.
Typ publikacji :: Journal Article; Meta-Analysis; Review; Systematic Review
MeSH Terms :: Neoplasm Recurrence, Local*
Rectal Fistula*/surgery
Adult ; Humans ; Male ; Middle Aged ; Recurrence ; Treatment Outcome ; Wound Healing
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 14 14.

Tytuł :: A two-part, single-arm, multicentre, phase I study of zanubrutinib, a selective Bruton tyrosine kinase inhibitor, in Chinese patients with relapsed/refractory B-cell malignancies.
Autorzy :: Song Y; Department of Lymphoma, Key laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital & Institute, Beijing, China.
Sun M; National Clinical Research Center for Blood Diseases, State Key Laboratory of Experimental Hematology, Blood Diseases Hospital & Institute of Hematology, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.
Qi J; National Clinical Research Center for Blood Diseases, State Key Laboratory of Experimental Hematology, Blood Diseases Hospital & Institute of Hematology, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.
Xu W; Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, China.
Zhou J; Department of Hematology, Tongji Hospital, Tongji Medical College, Wuhan, China.
Li D; Department of Hematology, Tongji Hospital, Tongji Medical College, Wuhan, China.
Li J; Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, China.
Qiu L; National Clinical Research Center for Blood Diseases, State Key Laboratory of Experimental Hematology, Blood Diseases Hospital & Institute of Hematology, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.
Du C; BeiGene (Beijing) Co., Ltd., Beijing, China.; BeiGene USA, Inc., San Mateo, California, USA.
Guo H; BeiGene (Beijing) Co., Ltd., Beijing, China.; BeiGene USA, Inc., San Mateo, California, USA.
Huang J; BeiGene (Beijing) Co., Ltd., Beijing, China.; BeiGene USA, Inc., San Mateo, California, USA.
Tang Z; BeiGene (Beijing) Co., Ltd., Beijing, China.; BeiGene USA, Inc., San Mateo, California, USA.
Ou Y; BeiGene (Beijing) Co., Ltd., Beijing, China.; BeiGene USA, Inc., San Mateo, California, USA.
Wu B; BeiGene (Beijing) Co., Ltd., Beijing, China.; BeiGene USA, Inc., San Mateo, California, USA.
Yu Y; BeiGene (Beijing) Co., Ltd., Beijing, China.; BeiGene USA, Inc., San Mateo, California, USA.
Zhu J; Department of Lymphoma, Key laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital & Institute, Beijing, China.; Pokaż więcej
Źródło :: British journal of haematology [Br J Haematol] 2022 Jul; Vol. 198 (1), pp. 62-72. Date of Electronic Publication: 2022 Apr 05.
Typ publikacji :: Clinical Trial, Phase I; Journal Article; Multicenter Study
MeSH Terms :: Neoplasm Recurrence, Local*/drug therapy
Neoplasm Recurrence, Local*/pathology
Protein Kinase Inhibitors*/adverse effects
Agammaglobulinaemia Tyrosine Kinase ; China ; Chronic Disease ; Humans ; Piperidines ; Pyrazoles ; Pyrimidines
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 15 15.

Tytuł :: Circulating Immune Cell and Outcome Analysis from the Phase II Study of PD-L1 Blockade with Durvalumab for Newly Diagnosed and Recurrent Glioblastoma.
Autorzy :: Nayak L; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
Standifer N; Integrated Bioanalysis, Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, South San Francisco, California.
Dietrich J; Department of Neurology, Massachusetts General Hospital, Boston, Massachusetts.
Clarke JL; Departments of Neurology and Neurosurgery, University of California, San Francisco, San Francisco, California.
Dunn GP; Department of Neurosurgery, Washington University School of Medicine, St. Louis, Missouri.
Lim M; Department of Neurosurgery, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Cloughesy T; Department of Neurology, University of California, Los Angeles, Los Angeles, California.
Gan HK; Department of Medical Oncology, Austin Health, Melbourne, Australia.
Flagg E; Department of Radiology, Brigham and Women's Hospital, Boston, Massachusetts.
George E; Department of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, California.
Gaffey S; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
Hayden J; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
Holcroft C; PROMETRIKA, LLC, New York, New York.
Wen PY; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
Macri M; Ludwig Cancer Research, New York, New York.
Park AJ; Ludwig Cancer Research, New York, New York.
Ricciardi T; Ludwig Cancer Research, New York, New York.
Ryan A; Ludwig Cancer Research, New York, New York.
Schwarzenberger P; Ludwig Cancer Research, New York, New York.
Venhaus R; Ludwig Cancer Research, New York, New York.
Reyes ML; Translational Medicine Oncology, Early and Early Oncology, R&D, Gaithersburg, Maryland.
Durham NM; Translational Medicine Oncology, Early and Early Oncology, R&D, Gaithersburg, Maryland.
Creasy T; Translational Medicine Oncology, Early and Early Oncology, R&D, Gaithersburg, Maryland.
Huang RY; Department of Radiology, Brigham and Women's Hospital, Boston, Massachusetts.
Kaley T; Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York.
Reardon DA; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Pokaż więcej
Źródło :: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2022 Jun 13; Vol. 28 (12), pp. 2567-2578.
Typ publikacji :: Clinical Trial, Phase II; Journal Article
MeSH Terms :: Dexamethasone*/therapeutic use
Glioblastoma*/drug therapy
Glioblastoma*/genetics
Glioblastoma*/pathology
Neoplasm Recurrence, Local*/drug therapy
Neoplasm Recurrence, Local*/pathology
Antibodies, Monoclonal ; B7-H1 Antigen/antagonists & inhibitors ; Bevacizumab/therapeutic use ; Biomarkers, Tumor/analysis ; Humans ; Ki-67 Antigen
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 16 16.

Tytuł :: Efficacy and Safety of Apatinib in Patients with Recurrent or Refractory Melanoma.
Autorzy :: Yuan S; Department of Immunotherapy, Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou, People's Republic of China.
Fu Q; Department of General Surgery, Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou, People's Republic of China.
Zhao L; Department of Immunotherapy, Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou, People's Republic of China.
Fu X; Department of Immunotherapy, Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou, People's Republic of China.
Li T; Department of Immunotherapy, Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou, People's Republic of China.
Han L; Department of Immunotherapy, Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou, People's Republic of China.
Qin P; Department of Immunotherapy, Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou, People's Republic of China.
Ren Y; Department of General Surgery, Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou, People's Republic of China.
Huo M; Department of General Surgery, Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou, People's Republic of China.
Li Z; Department of General Surgery, Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou, People's Republic of China.
Lu C; Department of General Surgery, Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou, People's Republic of China.
Yuan L; Department of General Surgery, Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou, People's Republic of China.
Gao Q; Department of Immunotherapy, Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou, People's Republic of China.
Wang Z; Department of Immunotherapy, Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou, People's Republic of China.; Pokaż więcej
Źródło :: The oncologist [Oncologist] 2022 Jun 08; Vol. 27 (6), pp. e463-e470.
Typ publikacji :: Clinical Trial, Phase II; Journal Article
MeSH Terms :: Melanoma*/drug therapy
Neoplasm Recurrence, Local*/drug therapy
Neoplasm Recurrence, Local*/pathology
Pyridines*/adverse effects
Antineoplastic Agents/therapeutic use ; Humans ; Hypertension/chemically induced ; Mucositis/chemically induced
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 17 17.

Tytuł :: Outcomes of adolescents with acute lymphoblastic leukaemia.
Autorzy :: Feng J; Department of Paediatrics, The Chinese University of Hong Kong, Hong Kong.; Department of Paediatrics, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, PR China.
Cheng FWT; Department of Paediatrics and Adolescent Medicine, Hong Kong Children's Hospital, Hong Kong.
Chiang AKS; Department of Paediatrics and Adolescent Medicine, Hong Kong Children's Hospital, Hong Kong.; Department of Paediatrics and Adolescent Medicine, The University of Hong Kong, Hong Kong.; Department of Paediatrics and Adolescent Medicine, Queen Mary Hospital, Hong Kong.
Lam GKS; Department of Paediatrics and Adolescent Medicine, Hong Kong Children's Hospital, Hong Kong.
Chow TTW; Department of Paediatrics and Adolescent Medicine, Hong Kong Children's Hospital, Hong Kong.
Ha SY; Department of Paediatrics and Adolescent Medicine, Hong Kong Children's Hospital, Hong Kong.; Department of Paediatrics and Adolescent Medicine, Queen Mary Hospital, Hong Kong.
Luk CW; Department of Paediatrics and Adolescent Medicine, Hong Kong Children's Hospital, Hong Kong.; Department of Paediatrics and Adolescent Medicine, Queen Elizabeth Hospital, Hong Kong.
Li CH; Department of Paediatrics and Adolescent Medicine, Tuen Mun Hospital, Hong Kong.
Ling SC; Department of Paediatrics and Adolescent Medicine, Princess Margaret Hospital, Hong Kong.
Yau PW; Department of Paediatrics and Adolescent Medicine, Hong Kong Children's Hospital, Hong Kong.; Department of Paediatrics and Adolescent Medicine, Queen Elizabeth Hospital, Hong Kong.
Ho KKH; Department of Paediatrics and Adolescent Medicine, Tuen Mun Hospital, Hong Kong.
Leung AWK; Department of Paediatrics, The Chinese University of Hong Kong, Hong Kong.; Department of Paediatrics and Adolescent Medicine, Hong Kong Children's Hospital, Hong Kong.; Department of Paediatrics, Prince of Wales Hospital, Hong Kong.
Chan NPH; Department of Anatomical and Cellular Pathology, The Chinese University of Hong Kong, Hong Kong.
Ng MHL; Department of Anatomical and Cellular Pathology, The Chinese University of Hong Kong, Hong Kong.
Li CK; Department of Paediatrics, The Chinese University of Hong Kong, Hong Kong.; Department of Paediatrics and Adolescent Medicine, Hong Kong Children's Hospital, Hong Kong.; Hong Kong Hub of Paediatrics Excellence, The Chinese University of Hong Kong, Hong Kong.; Pokaż więcej
Źródło :: Hong Kong medical journal = Xianggang yi xue za zhi [Hong Kong Med J] 2022 Jun; Vol. 28 (3), pp. 204-214. Date of Electronic Publication: 2022 Jun 14.
Typ publikacji :: Journal Article
MeSH Terms :: Neoplasm Recurrence, Local*/drug therapy
Precursor Cell Lymphoblastic Leukemia-Lymphoma*/drug therapy
Adolescent ; Antineoplastic Combined Chemotherapy Protocols ; Child ; Child, Preschool ; Disease-Free Survival ; Humans ; Incidence ; Retrospective Studies ; Survival Rate
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 18 18.

Tytuł :: Infigratinib in Patients with Recurrent Gliomas and FGFR Alterations: A Multicenter Phase II Study.
Autorzy :: Lassman AB; Division of Neuro-Oncology, Department of Neurology and Herbert Irving Comprehensive Cancer Center, Columbia University Vagelos College of Physicians and Surgeons and NewYork-Presbyterian, New York, New York.
Sepúlveda-Sánchez JM; Hospital Universitario 12 De Octubre, Madrid, Spain.
Cloughesy TF; University of California at Los Angeles, Los Angeles, California.
Gil-Gil MJ; Institut Català d'Oncologia, Hospitalet de Llobregat, Barcelona, Spain.
Puduvalli VK; Division of Neuro-Oncology, Ohio State University Wexner Medical Center, Columbus, Ohio.
Raizer JJ; Northwestern University, Department of Neurology, Section of Neuro-Oncology, Chicago, Illinois.
De Vos FYF; Department Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
Wen PY; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
Butowski NA; University of California San Francisco, San Francisco, California.
Clement PMJ; Leuven Cancer Institute, KU Leuven, Leuven, Belgium.
Groves MD; Texas Oncology PA, Austin, Texas.
Belda-Iniesta C; Hospital Universitario HM Sanchinarro, Madrid, Spain.
Giglio P; Division of Neuro-Oncology, Ohio State University Wexner Medical Center, Columbus, Ohio.
Soifer HS; QED Therapeutics, San Francisco, California.
Rowsey S; QED Therapeutics, San Francisco, California.
Xu C; QED Therapeutics, San Francisco, California.
Avogadri F; QED Therapeutics, San Francisco, California.
Wei G; QED Therapeutics, San Francisco, California.
Moran S; QED Therapeutics, San Francisco, California.
Roth P; Department of Neurology & Brain Tumor Center, University Hospital and University of Zurich, Zurich, Switzerland.; Pokaż więcej
Źródło :: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2022 Jun 01; Vol. 28 (11), pp. 2270-2277.
Typ publikacji :: Clinical Trial, Phase II; Journal Article; Multicenter Study
MeSH Terms :: Glioma*/drug therapy
Glioma*/genetics
Neoplasm Recurrence, Local*/drug therapy
Neoplasm Recurrence, Local*/genetics
Adult ; Follow-Up Studies ; Humans ; Microtubule-Associated Proteins ; Phenylurea Compounds ; Protein Kinase Inhibitors/adverse effects ; Pyrimidines ; Receptor, Fibroblast Growth Factor, Type 3/genetics
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 19 19.

Tytuł :: Lateral Lymph Nodes in Rectal Cancer: Do we all Think the Same? A Review of Multidisciplinary Obstacles and Treatment Recommendations.
Autorzy :: Sluckin TC; Department of Surgery, Amsterdam University Medical Centers, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, the Netherlands; Department of Radiation Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
Couwenberg AM; Department of Radiation Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
Lambregts DMJ; Department of Radiology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
Hazen SJA; Department of Surgery, Amsterdam University Medical Centers, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, the Netherlands.
Horsthuis K; Department of Radiology, Amsterdam University Medical Centers, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, the Netherlands.
Meijnen P; Department of Radiation Oncology, Amsterdam University Medical Centers, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, the Netherlands.
Beets-Tan RGH; Department of Radiology, The Netherlands Cancer Institute, Amsterdam, the Netherlands; GROW School of Oncology and Developmental Biology, University of Maastricht, Universiteitssingel 40, Maastricht, the Netherlands.
Tanis PJ; Department of Surgery, Amsterdam University Medical Centers, University of Amsterdam, Cancer Center Amsterdam, Amsterdam, the Netherlands; Department of Surgical Oncology and Gastrointestinal Surgery, Erasmus MC, Rotterdam, the Netherlands.
Marijnen CAM; Department of Radiation Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands; Department of Radiation Oncology, Leiden University Medical Centre, Leiden, the Netherlands.
Kusters M; Department of Surgery, Amsterdam University Medical Centers, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, the Netherlands. Electronic address: .; Pokaż więcej
Źródło :: Clinical colorectal cancer [Clin Colorectal Cancer] 2022 Jun; Vol. 21 (2), pp. 80-88. Date of Electronic Publication: 2022 Feb 19.
Typ publikacji :: Journal Article; Review
MeSH Terms :: Neoplasm Recurrence, Local*/diagnosis
Neoplasm Recurrence, Local*/pathology
Neoplasm Recurrence, Local*/therapy
Rectal Neoplasms*/diagnosis
Rectal Neoplasms*/pathology
Rectal Neoplasms*/therapy
Humans ; Lymph Nodes/pathology ; Neoadjuvant Therapy
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 20 20.

Tytuł :: Developing an immune-related gene prognostic index associated with progression and providing new insights into the tumor immune microenvironment of prostate cancer.
Autorzy :: Feng D; Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, 610041, China.
Zhang F; Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, 610041, China.
Li D; Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, 610041, China.
Shi X; Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, 610041, China.
Xiong Q; Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, 610041, China.
Wei Q; Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, 610041, China.
Yang L; Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, 610041, China.; Pokaż więcej
Źródło :: Immunology [Immunology] 2022 Jun; Vol. 166 (2), pp. 197-209. Date of Electronic Publication: 2022 Mar 16.
Typ publikacji :: Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't
MeSH Terms :: Neoplasm Recurrence, Local*/genetics
Neoplasm Recurrence, Local*/immunology
Neoplasm Recurrence, Local*/surgery
Prostatic Neoplasms*/genetics
Prostatic Neoplasms*/immunology
Prostatic Neoplasms*/surgery
Tumor Microenvironment*/immunology
Humans ; Male ; Neoplasm Grading ; Prognosis ; Prostatectomy
: Czasopismo naukowe

Szczegóły

Informacja

Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Recurrence"" wg kryterium: Temat

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język